← Back to Search

Airway Stabilizing Device for Airway Complication (FASTER Trial)

N/A

Recruiting

Led By Arvind Chandrakantan, MD

Research Sponsored by Baylor College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 minutes

Awards & highlights

FASTER Trial Summary

This trial tested the use of the LMA as a primary device in pediatric patients who needed intubation.

Who is the study for?

This trial is for children and teenagers aged 5-18 who can have a laryngeal mask airway (LMA) placed, need intubation, and are known to have difficult airways. It's not specified who cannot participate.Check my eligibility

What is being tested?

The study is testing how quickly a device called the FASTER can help with intubation in young patients with challenging airways compared to standard methods.See study design

What are the potential side effects?

While specific side effects aren't listed, procedures involving intubation may include risks such as sore throat, difficulty swallowing, or more rarely, injury to the airway.

FASTER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall time in the airway

Total time to intubation

FASTER Trial Design

1Treatment groups

Experimental Treatment

Group I: Time to intubation using FASTER deviceExperimental Treatment1 Intervention

Time from fiberoptic placement into airway to documentation of end-tidal carbon dioxide waveform through the endotracheal tube.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor

1,001 Previous Clinical Trials

6,002,392 Total Patients Enrolled

Arvind Chandrakantan, MDPrincipal InvestigatorBaylor College of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total enrollment number for this clinical investigation?

"Affirmative. The clinical trial listing on clinicaltrials.gov confirms that recruitment is underway for this medical study, which was originally published on October 12th 2023 and most recently updated November 14th 2023. There are positions available at a single site location requiring the enrollment of only 20 individuals."

Answered by AI

What is the eligibility criteria for participating in this medical trial?

"In order to qualify for this study, candidates must be between the ages of 5 and 18, display signs of airway complications, and meet other requirements. The research team is trying to enrol 20 participants in total."

Answered by AI

Are there openings to partake in this experiment for participants?

"The study is currently open for patient recruitment with the initial posting having occurred on October 12th, 2023 and latest update being published November 14th of the same year. Data hosted at clinicaltrials.gov verifies this information."

Answered by AI

Is this medical experiment open to geriatric participants?

"Participants of this clinical trial must range from 5-18 years old to be considered eligible. Additionally, there are 3 studies that will focus on the pediatric population and 2 for those aged over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Utilization of Airway Stabilizing Rod

Arvind Chandrakantan 2023. "Utilization of Airway Stabilizing Rod". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05899868.